search
Back to results

Lipofilling for Healing of Chronic Wounds

Primary Purpose

Wound Healing Disorder

Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Lipofilling (sublesional fat grafting)
Sponsored by
University of Witten/Herdecke
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Wound Healing Disorder

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Patients with leg ulcers of any origin (venous, arterial, mixed arterial-venous, diabetogenic, compressive)
  • Age of ulcer > 6 weeks
  • Ulcer size >= 1 cm (minimum diameter)
  • Ulcer / wound with complete destruction of the epidermis (including basement membrane)
  • Patient age > 18 years
  • Patient Consent

Exclusion Criteria:

  • Pregnancy
  • Exposed tendons, ligaments, or bone if maximum diameter > 2 mm
  • Ulcer size > 10 cm
  • Immediately preceding vacuum bandage therapy (< 2 weeks)
  • Possibilities for correcting the cause of the ulcer

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Experimental

    No Intervention

    Arm Label

    Intervention group

    Control group

    Arm Description

    The intervention group received a fat grafting under the wound bed and into the wound edges.

    The control group received an injection of saline solution (0.9%) under the wound bed and into the wound edges.

    Outcomes

    Primary Outcome Measures

    Reduction of wound area
    The reduction of the wound area from intervention to 14 days and 2 month post-intervention

    Secondary Outcome Measures

    Pain wound
    Subjective pain level of the patient in the area of the wound, measured by the visual analogue scale pre and post intervention
    Bacterial contamination wound
    Wound swabs were taken pre intervention and on days 7, 14 and 21 after intervention

    Full Information

    First Posted
    August 18, 2022
    Last Updated
    August 18, 2022
    Sponsor
    University of Witten/Herdecke
    Collaborators
    Cologne-Merheim Medical Center (CMMC)
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT05509673
    Brief Title
    Lipofilling for Healing of Chronic Wounds
    Official Title
    Clinical Trial to Improve Wound Healing of Chronic Lower Leg Ulcers by Autologous Transplantation of Fat Tissue
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    August 2022
    Overall Recruitment Status
    Completed
    Study Start Date
    June 29, 2011 (Actual)
    Primary Completion Date
    November 30, 2016 (Actual)
    Study Completion Date
    March 6, 2017 (Actual)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Sponsor
    Name of the Sponsor
    University of Witten/Herdecke
    Collaborators
    Cologne-Merheim Medical Center (CMMC)

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No
    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    Chronic wounds remain a therapeutic and financial challenge for physicians and the health care systems. Innovative, cheap and effective treatment methods would be of immense value. The sublesional fat grafting could be such treatment, although the effectiveness and safety have not been assessed in large randomized clinical trials. The aim of this trial was to analyse the effect of adipose tissue on the healing of chronic lower leg wounds. For this purpose, the wounds were surgically cleaned (wound debridement) and then fat was suctioned out from the stomach or thighs and then injected into the edges of the wound and under the wounds. The wounds are covered with a foam dressing that is changed every 3-4 days. There are controls on days 3, 7, 14 and 21 after the intervention and a follow-up examination 2 months after the intervention. The primary objective is the reduction of the wound area 14 days and 2 month after intervention. Secondary objectives are pain level of the wound, bacterial colonialisation of the wound and analysis of the grafted fat tissue (ammount of mesenchymal stem cells)

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Wound Healing Disorder

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Not Applicable
    Interventional Study Model
    Single Group Assignment
    Masking
    Outcomes Assessor
    Masking Description
    Digital analysis of wound area is masked
    Allocation
    Randomized
    Enrollment
    34 (Actual)

    8. Arms, Groups, and Interventions

    Arm Title
    Intervention group
    Arm Type
    Experimental
    Arm Description
    The intervention group received a fat grafting under the wound bed and into the wound edges.
    Arm Title
    Control group
    Arm Type
    No Intervention
    Arm Description
    The control group received an injection of saline solution (0.9%) under the wound bed and into the wound edges.
    Intervention Type
    Other
    Intervention Name(s)
    Lipofilling (sublesional fat grafting)
    Primary Outcome Measure Information:
    Title
    Reduction of wound area
    Description
    The reduction of the wound area from intervention to 14 days and 2 month post-intervention
    Time Frame
    14 days and 2 month
    Secondary Outcome Measure Information:
    Title
    Pain wound
    Description
    Subjective pain level of the patient in the area of the wound, measured by the visual analogue scale pre and post intervention
    Time Frame
    2 month
    Title
    Bacterial contamination wound
    Description
    Wound swabs were taken pre intervention and on days 7, 14 and 21 after intervention
    Time Frame
    3 weeks

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: Patients with leg ulcers of any origin (venous, arterial, mixed arterial-venous, diabetogenic, compressive) Age of ulcer > 6 weeks Ulcer size >= 1 cm (minimum diameter) Ulcer / wound with complete destruction of the epidermis (including basement membrane) Patient age > 18 years Patient Consent Exclusion Criteria: Pregnancy Exposed tendons, ligaments, or bone if maximum diameter > 2 mm Ulcer size > 10 cm Immediately preceding vacuum bandage therapy (< 2 weeks) Possibilities for correcting the cause of the ulcer
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Oliver C Thamm, MD, PhD
    Organizational Affiliation
    University of Witten/Herdecke
    Official's Role
    Principal Investigator

    12. IPD Sharing Statement

    Plan to Share IPD
    No

    Learn more about this trial

    Lipofilling for Healing of Chronic Wounds

    We'll reach out to this number within 24 hrs